Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 34 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 11026997

    Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  2. US 11026889

    Polymeric drug delivery systems for treatment of disease

    The Board of Regents of the University of Texas System · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  3. US 11020383

    Methods for the treatment of cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  4. US 11020365

    Mixture of fatty acids for use in the treatment of inflammatory pathologies

    AGAIN LIFE ITALIA SRL · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  5. US 11020417

    Methods and compounds for treatment of lymphocyte-related diseases and conditions

    Sarepta Therapeutics, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  6. US 11021424

    Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

    PTC THERAPEUTICS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  7. US 11013713

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  8. US 11013743

    Cancer treatments using combinations of CDK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  9. US 11013740

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted
  10. US 11013787

    Sustained release formulation of interleukin-10 for wound treatment and related methods

    THE REGENTS OF THE UNIVERSITY OF COLORADO FOR AND ON BEHALF OF THE UNIVERSITY OF COLORADO DENVER · Granted May 25, 2021 · Expires May 20, 2041

    granted
  11. US 11007183

    Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  12. US 11007184

    Cancer treatments using combinations of type 2 MEK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  13. US 11007157

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  14. US 11007171

    Treatment and prevention of joint disorders

    Summit Innovation Labs LLC · Granted May 18, 2021 · Expires May 13, 2041

    granted
  15. US 11007255

    Cancer vaccines and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  16. US 11001594

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted May 11, 2021 · Expires May 6, 2041

    granted
  17. US 10995068

    Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment

    The Regents of the University of California · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  18. US 10995328

    Materials and methods for treatment of autosomal dominant cone-rod dystrophy

    CRISPR THERAPEUTICS AG · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  19. US 10993956

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  20. US 10987434

    Detection and treatment of caries and microcavities with nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  21. US 10987373

    DNA origami nanostructures for treatment of acute kidney injury

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  22. US 10988778

    Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  23. US 10987346

    Iloperidone for the treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  24. US 10981951

    Therapeutics for the treatment of glaucoma

    Regents of the University of Minnesota · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted